SMS Lifesciences India Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 3/6
SMS Lifesciences India has a total shareholder equity of ₹1.9B and total debt of ₹1.0B, which brings its debt-to-equity ratio to 52%. Its total assets and total liabilities are ₹3.9B and ₹2.0B respectively. SMS Lifesciences India's EBIT is ₹299.5M making its interest coverage ratio 2.9. It has cash and short-term investments of ₹14.9M.
Anahtar bilgiler
52.0%
Borç/özkaynak oranı
₹1.01b
Borç
| Faiz karşılama oranı | 2.9x |
| Nakit | ₹14.93m |
| Eşitlik | ₹1.94b |
| Toplam yükümlülükler | ₹1.97b |
| Toplam varlıklar | ₹3.91b |
Son finansal sağlık güncellemeleri
Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?
Aug 01
SMS Lifesciences India (NSE:SMSLIFE) Use Of Debt Could Be Considered Risky
Feb 10SMS Lifesciences India (NSE:SMSLIFE) Takes On Some Risk With Its Use Of Debt
Jun 03Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?
Feb 22Does SMS Lifesciences India (NSE:SMSLIFE) Have A Healthy Balance Sheet?
Nov 24Recent updates
Improved Earnings Required Before SMS Lifesciences India Limited (NSE:SMSLIFE) Stock's 58% Jump Looks Justified
Aug 27Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?
Aug 01SMS Lifesciences India Limited (NSE:SMSLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Market
Jun 13SMS Lifesciences India (NSE:SMSLIFE) Use Of Debt Could Be Considered Risky
Feb 10There's Reason For Concern Over SMS Lifesciences India Limited's (NSE:SMSLIFE) Massive 30% Price Jump
Jan 05Should Shareholders Reconsider SMS Lifesciences India Limited's (NSE:SMSLIFE) CEO Compensation Package?
Sep 23SMS Lifesciences India (NSE:SMSLIFE) Is Paying Out A Dividend Of ₹1.50
Sep 07SMS Lifesciences India (NSE:SMSLIFE) Has Affirmed Its Dividend Of ₹1.50
Aug 24SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50
Sep 16SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50
Sep 02SMS Lifesciences India (NSE:SMSLIFE) Takes On Some Risk With Its Use Of Debt
Jun 03With EPS Growth And More, SMS Lifesciences India (NSE:SMSLIFE) Is Interesting
May 13SMS Lifesciences India's (NSE:SMSLIFE) Solid Profits Have Weak Fundamentals
Nov 23Is Now The Time To Put SMS Lifesciences India (NSE:SMSLIFE) On Your Watchlist?
Jun 21Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?
Feb 22SMS Lifesciences India Limited's (NSE:SMSLIFE) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Jan 04Insider Buying: The SMS Lifesciences India Limited (NSE:SMSLIFE) MD & Executive Director Just Bought 19% More Shares
Nov 27Does SMS Lifesciences India (NSE:SMSLIFE) Have A Healthy Balance Sheet?
Nov 24Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: SMSLIFE's short term assets (₹1.6B) exceed its short term liabilities (₹1.4B).
Uzun Vadeli Yükümlülükler: SMSLIFE's short term assets (₹1.6B) exceed its long term liabilities (₹523.2M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: SMSLIFE's net debt to equity ratio (51.2%) is considered high.
Borcun Azaltılması: SMSLIFE's debt to equity ratio has increased from 37.6% to 52% over the past 5 years.
Borç Kapsamı: SMSLIFE's debt is well covered by operating cash flow (24.1%).
Faiz Kapsamı: SMSLIFE's interest payments on its debt are not well covered by EBIT (2.9x coverage).